We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.03%
3 Healthcare 14.17%
4 Industrials 13.91%
5 Financials 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXU
1726
DELISTED
Alexco Resource Corp
AXU
-312,555
Closed -$825K
ATHX
1727
DELISTED
Athersys, Inc. Common Stock
ATHX
-2,030
Closed -$99K
CDR
1728
DELISTED
Cedar Realty Trust, Inc
CDR
-14,167
Closed -$76K
RDUS
1729
DELISTED
Radius Health, Inc.
RDUS
-14,617
Closed -$166K
EPZM
1730
DELISTED
Epizyme, Inc
EPZM
-79,582
Closed -$949K
SREV
1731
DELISTED
ServiceSource International, Inc.
SREV
-224,148
Closed -$329K
CDK
1732
DELISTED
CDK Global, Inc.
CDK
-14,165
Closed -$617K
NP
1733
DELISTED
Neenah, Inc. Common Stock
NP
-6,729
Closed -$252K
ANAT
1734
DELISTED
American National Group, Inc. Common Stock
ANAT
-3,390
Closed -$229K
XENT
1735
DELISTED
Intersect ENT, Inc
XENT
-27,171
Closed -$443K
FOE
1736
DELISTED
Ferro Corporation
FOE
-22,169
Closed -$275K
RVI
1737
DELISTED
Retail Value Inc. Common Shares
RVI
-149,569
Closed -$173K
ORPH
1738
DELISTED
Orphazyme A/S
ORPH
-490,000
Closed -$5.06M
CONE
1739
DELISTED
CyrusOne Inc Common Stock
CONE
-5,572
Closed -$390K
RDS.A
1740
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-14,846
Closed -$374K
MGLN
1741
DELISTED
Magellan Health Services, Inc.
MGLN
-2,690
Closed -$204K
ATH
1742
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
-7,130
Closed -$243K
HRC
1743
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
-12,165
Closed -$1.02M
CXP
1744
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
-46,629
Closed -$509K
RAVN
1745
DELISTED
Raven Industries Inc
RAVN
-45,945
Closed -$989K
EBSB
1746
DELISTED
Meridian Bancorp, Inc.
EBSB
-28,611
Closed -$296K
ARD
1747
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
-10,200
Closed -$143K
BOCH
1748
DELISTED
Bank of Commerce Holdings (CA)
BOCH
-13,276
Closed -$93K
SOGO
1749
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
-13,393
Closed -$119K
TBIO
1750
DELISTED
Translate Bio, Inc. Common Stock
TBIO
-21,857
Closed -$297K

Similar funds

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.